![Phillip Dennis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Phillip Dennis
Hoofd Techniek/Wetenschap/O&O bij
NOVABRIDGE BIOSCIENCES
Vermogen: 137 207 $ op 31-08-2026
Profiel
Dr. Phillip Dennis is a Chief Medical Officer at NovaBridge Biosciences and a Member at American Society for Clinical Investigation.
He received his graduate degree from New York University School of Medicine and a doctorate degree from New York University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-09-2026 | 173.427 ( 0,09% ) | 137 207 $ | 31-08-2026 |
Actieve functies van Phillip Dennis
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Hoofd Techniek/Wetenschap/O&O | 17-06-2024 |
American Society for Clinical Investigation
 American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Corporate Officer/Principal | - |
Opleiding van Phillip Dennis
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
72
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
